Washington State lawmakers have introduced Senate Bill 5622, a legislative measure aimed at regulating the sale of over-the-counter diet pills and dietary supplements for weight loss or muscle building. Introduced on February 20, 2025, the bill seeks to address growing concerns about the accessibility of these products to minors, particularly those under 18 years of age.

The bill outlines specific identification requirements for purchasers, mandating that they present officially issued identification that verifies their age and includes a signature and photograph. Acceptable forms of ID include state-issued driver’s licenses, military identification, passports, and tribal enrollment cards, among others. Notably, individuals who appear to be at least 25 years old are exempt from showing ID, although this does not protect sellers from legal repercussions if they inadvertently sell to minors.

A key provision of SB 5622 allows retail establishments to conduct transaction scans as a prerequisite for purchasing these products. If the scan reveals discrepancies with the identification or indicates fraudulent information, the transaction must be denied. This measure aims to enhance accountability and ensure that sellers are diligent in verifying the age of their customers.

The bill has sparked discussions among lawmakers and stakeholders regarding its implications. Proponents argue that it is a necessary step to protect youth from potentially harmful substances, while opponents raise concerns about the feasibility of implementing transaction scans in all retail settings. Additionally, there are worries about the potential burden on small businesses that may struggle to comply with the new regulations.

As the bill progresses through the legislative process, its outcomes could have significant social implications, particularly in shaping how dietary supplements are marketed and sold in Washington. If passed, SB 5622 may set a precedent for similar regulations in other states, reflecting a growing trend towards stricter controls on health-related products aimed at young consumers. The next steps will involve further debates and potential amendments as lawmakers seek to balance public health interests with business considerations.